We propose a model whereby in chronic phase CML there is an expansion of BCR/ABL positive CML progenitor cells that maintain the ability to undergo apoptosis and differentiation. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.